Tata 1mg ‘Grand Saving Days,’ India’s biggest health and wellness sale, to begin Sept 16, 2022. Spreading festive cheer ahead of the festival season, Tata 1mg, India’s largest digital health platform, has announced … Read More
Despite the rising incidence of chronic and lifestyle illnesses and an ever-increasing economic burden on households, generic medicines barely command any market share of drug sales in India. In fact, … Read More
Dipna Pharmachem Limited became the 389th company to get listed on the BSE SME. Dipna Pharmachem Limited became the 389th company to get listed on the BSE SME Platform on September 08, … Read More
Merck India announced its 10th Merck Bioforum India 2022. The move towards next-generation bioprocessing is real and is happening now. 10th Merck Bioforum India 2022 is a thought leadership program which is … Read More
IOL Chemicals and Pharmaceuticals Reports Q1 FY23 Results.OL Chemicals and Pharmaceuticals Limited, a leading manufacturer of pharmaceutical (APIs) and specialty chemicals reported results for the first quarter ended June 30, … Read More
PharmaTech Expo Inaugural by Shri Rushikeshbhai Patel Minister of Health and Family Welfare.Shri Rushikeshbhai Patel Honourable Minister of Health and Family Welfare, Government Of Gujarat inaugurated Western India’s Largest PharmaTech … Read More
Alembic reports revenue for Q1 FY23 Rs. 1262 Cr. Alembic Pharmaceuticals Limited reported its consolidated financial results for the quarter ending 30th June, 2022 Mr. Shaunak Amin, Managing Director, Alembic Pharmaceuticals … Read More
Sun Pharma reports Q1FY23 results.Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) reported financials for the first quarter ending June 30th, 2022. Highlights of Q1FY23 consolidated … Read More
Sun Pharma and Cosmo Announce Territory Expansion of License and Supply Agreements for WINLEVI® to include Japan, Australia, New Zealand, Brazil, Mexico and Russia. Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP … Read More
Sun Pharma to launch Brillo®, a first-in-class oral lipid-lowering drug in India. Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomb: SUNP IN, NSE: SUNPHARMA, BSE: 524715, “Sun Pharma” and includes its subsidiaries and/or associate companies) today announced that one of its wholly-owned subsidiaries plans to launch a first-in-class oral drug, Bempedoic … Read More
